This was the first study to systematically demonstrate that tirzepatide not only induces substantial weight loss but also shows improvements in sleep-disordered breathing among obese individuals

[1] Contact your GP or diabetes care team if you notice: Consistently elevated blood glucose readings HbA1c rising above your agreed target Unexplained weight gain Return of diabetes symptoms (increased thirst, frequent urination, fatigue) Severe and persistent abdominal pain (with or without vomiting), which could indicate pancreatitis Symptoms of gallbladder disease (pain in upper right abdomen, nausea, vomiting) Signs of dehydration (dizziness, dry mouth, reduced urination) New or worsening visual symptoms, particularly if you have diabetic retinopathy Your healthcare provider may consider dose escalation (Ozempic starts at 0.25 mg weekly for 4 weeks as an initiation dose only, then 0.5 mg, with possible increases to 1 mg and 2 mg weekly doses if needed and tolerated) or investigate other factors affecting your diabetes control

[2] Phentermine maintains a long-standing record in obesity treatment, receiving FDA approval as a resin complex in 1959 and then as a hydrochloride salt in 1973 for short-term weight management
The FDA requires the packaging of most anti-seizure medications, including Topamax, to contain a warning about the possibility of suicidal thoughts